All articles by David Shlaes

The Economic Conundrum for Antibacterial Drugs
( )
It's the Resistance, Stupid!
( )
Stuart Levy, Giant in the Fight Against Resistance, is Gone
( )
Incentives from Medicare?
( )
How Expert Societies Could Help the Economics of Antibiotics
( )
Musings on the Future of Antibiotic Biotech
( )
Antibiotics: Motivating Investors
( )
Antibiotics, Investors & Where We Go from Here
( )
Pull Incentives on Antibiotics? Don’t Hold Your Breath
( )
Non-Traditional Antibacterials
( )
Antibiotics: Play or Pay?
( )
The UK Plan: Tackling Antimicrobial Resistance
( )
Musings on Penicillin: Can We Learn from History?
( )
What's Ahead for Antibiotics in 2019?
( )
Melinta, Are We Getting the Message?
( )
Antibiotic Awareness Week - Talk vs. Action?
( )
REVAMP: Congress Contemplates a Fix for Antibiotic Resistance
( )
When It Comes To Flu Vaccine, Buyer Beware. Especially if You're Older.
( )
Big News -- FDA Delays Again
( )
We Can't Just Subsidize Back to Antibiotics Leadership
( )
An Industry Veteran Argument For Fixed Drug Prices
( )
ACSH relies on donors like you. If you enjoy our work, please contribute.

Make your tax-deductible gift today!

 

 

Popular articles

ACSH Podcasts